| 000 | 01749 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514224611.0 | ||
| 264 | 0 | _c20050809 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jc.2005-0208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMauras, Nelly | |
| 245 | 0 | 0 |
_aLimited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cJul 2005 |
||
| 300 |
_a3946-55 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBody Composition |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 | _aCarbohydrate Metabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aExercise Test |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Protein 3 _xblood |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aPescovitz, Ora Hirsch | |
| 700 | 1 | _aAllada, Vivek | |
| 700 | 1 | _aMessig, Michael | |
| 700 | 1 | _aWajnrajch, Michael P | |
| 700 | 1 | _aLippe, Barbara | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 90 _gno. 7 _gp. 3946-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2005-0208 _zAvailable from publisher's website |
| 999 |
_c15522231 _d15522231 |
||